Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Br J Surg ; 103(13): 1847-1854, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-27696376

RESUMO

BACKGROUND: Achalasia can be subdivided into manometric subtypes according to the Chicago classification. These subtypes are proposed to predict outcome after treatment. This hypothesis was tested using a database of patients who underwent laparoscopic Heller's cardiomyotomy with anterior fundoplication. METHODS: All patients who underwent Heller's cardiomyotomy for achalasia between June 1993 and March 2015 were identified from an institutional database. Manometry tracings were retrieved and re-reported according the Chicago classification. Outcome was assessed by a postal questionnaire, and designated a success if the modified Eckardt score was 3 or less, and the patient had not undergone subsequent surgery or pneumatic dilatation. Difference in outcome after cardiomyotomy was analysed with a mixed-effects logistic regression model. RESULTS: Sixty, 111 and 24 patients had type I, II and II achalasia respectively. Patients with type III achalasia were more likely to be older than those with type I or II (mean age 63 versus 50 and 49 years respectively; P = 0·001). Some 176 of 195 patients returned questionnaires after surgery. Type III achalasia was less likely to have a successful outcome than type II (odds ratio (OR) 0·38, 95 per cent c.i. 0·15 to 0·94; P = 0·035). There was no significant difference in outcome between types I and II achalasia (II versus I: OR 0·87, 0·47 to 1·60; P 0·663). The success rate at 3-year follow-up was 69 per cent (22 of 32) for type I, 66 per cent (33 of 50) for type II and 31 per cent (4 of 13) for type III. CONCLUSION: Type III achalasia is a predictor of poor outcome after cardiomyotomy. There was no difference in outcome between types I and II achalasia.


Assuntos
Acalasia Esofágica/cirurgia , Esôfago/cirurgia , Fundoplicatura/métodos , Acalasia Esofágica/fisiopatologia , Feminino , Humanos , Laparoscopia/métodos , Masculino , Manometria/métodos , Pessoa de Meia-Idade , Resultado do Tratamento
3.
J Anat ; 200(Pt 1): 69-79, 2002 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11837252

RESUMO

Evans Blue Dye (EBD) is widely used to study cellular membrane permeability and has recently been utilised in mdx mice to identify permeable skeletal myofibres that have become damaged as a result of muscular dystrophy. EBD has the potential to be a useful vital stain of myofibre permeability in other models of skeletal muscle injury and membrane-associated fragility. The parameters for its use for such purposes were optimised in the present study, of particular interest is the use of EBD to identify the onset of muscle damage. This study compared intravenous vs. intraperitoneal injection; tissue fixation; volume of EBD; time of availability in tissue; and persistence after injection in mdx mice (with endogenous muscle damage) and control mice. Satisfactory labelling of permeable myofibres was seen in frozen sections viewed with fluorescence microscopy when intraperitoneal injection of a 1% EBD solution injected at 1% volume relative to body mass was administered between 16 and 24 h prior to tissue sampling. EBD labelling was then assessed in three mouse models of experimental injury and repair-cut injury, whole muscle grafts, and exercise-induced muscle damage. These experiments demonstrated that (i) following a cut injury across myofibres, EBD penetrated up to 150 microm from the injury site over a 20-h period; (ii) EBD was present throughout myofibres of avascular whole muscle graft by one day after transplantation; and (iii) damaged myofibres were detected within 20 min after controlled lengthening-contraction exercise. This simple and inexpensive technique has sensitivity for the detection of increased myofibre permeability and/or sublethal damage that has advantages over other traditional histological techniques at the light microscopy level.


Assuntos
Corantes/análise , Azul Evans/análise , Fibras Musculares Esqueléticas/patologia , Músculo Esquelético/lesões , Distrofias Musculares/patologia , Animais , Permeabilidade da Membrana Celular , Corantes/farmacocinética , Azul Evans/farmacocinética , Imuno-Histoquímica , Injeções Intraperitoneais , Injeções Intravenosas , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos mdx , Microscopia de Fluorescência , Modelos Animais , Fibras Musculares Esqueléticas/metabolismo , Músculo Esquelético/patologia , Músculo Esquelético/transplante , Distrofias Musculares/metabolismo , Condicionamento Físico Animal
4.
Aust J Physiother ; 38(2): 85-92, 1992.
Artigo em Inglês | MEDLINE | ID: mdl-25025640

RESUMO

Twenty four uninjured female volunteers (mean age = 19.6 years) were utilised to study the effect of modified Gibney ankle strapping on proprioception before, during and after exercise, by measuring performance on an instrumented wobbleboard. Following a familiarisation session, testing was conducted on two occasions using a crossover research design, utilising strapped and unstrapped conditions. The time in contact, the number of contacts and the average time in contact that the wobbleboard made with a metal baseplate under the wobbleboard were recorded during a ten second test duration. Tests were conducted at the times of 0, 5, 10 and 15 minutes of a standardised exercise regime performed by the subjects. Results revealed that strapping had no significant effect on wobbleboard performance. Since the wobbleboard is widely accepted as a method of training as well as a clinical assessment of ankle proprioception, it could be inferred that strapping had no effect on proprioception before, during or after exercise.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA